|
?:authorAffiliation
|
-
[\'Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.\', \'Janssen Vaccines and Prevention BV, Leiden, The Netherlands.\', \'Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.\', \'Massachusetts Institute of Technology, Cambridge, MA, USA.\', \'University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.\', \'Harvard Medical School, Boston, MA, USA.\', \'Bioqual, Rockville, MD, USA.\', \'Children\'s Hospital, Boston, MA, USA.\', \'Massachusetts Consortium on Pathogen Readiness, Boston, MA, USA.\', \'Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. dbarouch@bidmc.harvard.edu.\', \'Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA. dbarouch@bidmc.harvard.edu.\', \'Harvard Medical School, Boston, MA, USA. dbarouch@bidmc.harvard.edu.\', \'Massachusetts Consortium on Pathogen Readiness, Boston, MA, USA. dbarouch@bidmc.harvard.edu.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}